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International Neuropsychiatric Association
As professional organizations go, the International Neuropsychiatric Association
(INA) is young, having been formed in 1998 when a group of neuropsychiatrists met
in Toronto, Canada, to consider the status of their profession. There was a shared
sense of optimism, with a feeling that their time had come. They seemed ready to
proclaim their professional identity in the form of an association and to meet the
immediate challenges.
Defining neuropsychiatry and thereby the legitimate territory for a
neuropsychiatrist was the first and most difficult challenge. This generated much
discussion and eventually a compromise: “Neuropsychiatry is a field of scientific
medicine that concerns itself with the complex relationship between human behavior
and brain function, and endeavors to understand abnormal behavior and behavioral
disorders on the basis of an interaction of neurobiological and psychological–social
factors. It is rooted in clinical neuroscience and provides a bridge between the
disciplines of Psychiatry, Neurology and Neuropsychology”. The definition
emphasizes the scientific underpinnings of the profession and its hybrid origin. The
INA was therefore mandated to admit professionals from a diverse range of
backgrounds, and was seen as a forum for interaction between these overlapping
disciplines.
The second challenge was to define the clinical and research territory that
neuropsychiatry could lay claim to. Some would consider this unnecessary, being
content with the establishment of a neuropsychiatric approach that could be applied
to all brain disorders. However, a profession needs to fence in a territory to be able to
establish an identity and a raison d’etre for its existence. There are many disorders
that currently fit the bill of being “neuropsychiatric”. What characterizes them is that
the principles of either psychiatry or neurology are unable to fully encapsulate these
disorders, and the neuropsychiatric approach is needed for their diagnosis and
management. The diagnoses that come to mind are neurocognitive disorders (including
the dementias and mild cognitive impairment), drug-induced movement disorders,
Tourette’s syndrome, psychiatric disorders associated with other movement disorders
such as Parkinson’s disease and dystonia, those associated with epilepsy,
cerebrovascular disease, and head injury, chronic fatigue syndrome and other
psychoneuroimmunological disorders, attention deficit hyperactivity disorder, and
other conditions in which cognitive, behavioral, or affective disturbance results
directly from brain insult. Together, these disorders comprise a body of clinical work
that can underpin a robust discipline. While some neuropsychiatrists claim
schizophrenia, bipolar disorder, melancholic depression, and obsessive compulsive
disorder, these disorders remain the province of general psychiatrists with perhaps
some input from neuropsychiatrists in the management of resistant cases with novel
treatment techniques such as transcranial magnetic stimulation, vagus nerve
stimulation, deep brain stimulation, leukotomy, and in the future, genetic and stem
cell therapies.
The third challenge was to make the INA truly international. This had an auspicious
start with the interim executive committee comprising 12 countries. Many countries
already had fully established neuropsychiatric associations, which included the United
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States, Britain, Japan, Korea, Argentina, Mexico, and others.
In some other countries neuropsychiatry was the prevailing
zeitgeist for all psychiatric disorders, stemming perhaps
from a 19th century European legacy. The INA wished to
work closely with national and regional associations while
respecting their independence. It tried to achieve
international representation by forming an international
steering committee and seeking membership from across
the globe. At last examination, the association had members
from 40 countries with all continents represented. Its
biannual congresses have been held in Canada, Japan,
Argentina, and Greece. The INA’s mission states: “While
its scope is world-wide, its efforts will be particularly
directed towards those societies in which neuropsychiatric
disorders are not well recognised or remain a low priority
in health care”. The scope of this work has barely begun.
To achieve its mission of making a difference to the lives
of individuals with neuropsychiatric disorders around the
globe, the INA must do a number of things. First, the extent
of the problem must be defined. While epidemiological data
exist for the major psychiatric and neurological disorders,
we only have rough estimates for many neuropsychiatric
disorders. Some of these data are affected by controversies
in definition. For example, even for a relatively well defined
disorder such as Tourette’s syndrome, we have widely
varying prevalence rates from 0.001% to 2%. The prevalence
of adult attention deficit hyperactivity disorder will only be
addressed once the controversy pertaining to its validity can
be resolved. The epidemiology of dementia of late life has
been thoroughly investigated but early-onset dementia has
been neglected. Moreover, much of the data emanates from
industrialized countries and are not readily applicable
elsewhere. The INA, through its network of researchers and
clinicians, can facilitate the gathering of better quality data
for the entire range of neuropsychiatric disorders.
Second, models of service must be developed that can
be tailored to regional requirements. The intent in general
is to make neuropsychiatry a tertiary-level service with
established referral patterns from psychiatry, neurology,
geriatrics, and general medicine. The nature of the expertise
required makes it necessary that the core services for
neuropsychiatric diagnosis and assessment develop in
academic centers that have access to high-quality
neuroimaging and neurophysiology, and the back-up of
other specialties for their input. The lack of neuroimaging
and neurophysiology in some regions will pose a challenge
to diagnosticians. Since many neuropsychiatric patients need
medium- and long-term hospitalization for cognitive therapy
or rehabilitation, the assessment services will need the
support of medium- and long-term beds with appropriate
models of care. Practical models for such services are
urgently needed, and these will vary in detail from region
to region depending on local imperatives. The INA has a
role in advocating at the governmental level for patients who
are often unheard, and in supporting the development and
testing of suitable models of care.
Third, the INA should invest in the training of future
members. This can begin with the development of an
international curriculum, which can be modified to meet
local needs. Important decisions have to be made in relation
to the composition of the training deemed necessary. In some
instances, the training can be provided in well resourced
centers so that the skills can be exported. For this, an
international fellowships program needs to be fostered. In
the long term, training must occur in all large countries so
that local needs can be fulfilled.
Fourth, the INA must support research. With the
explosion in neuroscience, the research agenda is broad and
there is no dearth of new ideas. The INA can assist by
supporting collaborations, not only with psychiatry and
neurology, but also with neuropsychology, genetics,
psychopharmacology, diagnostic radiology, immunology,
neurophysiology, rehabilitation, and many other disciplines.
As resources develop, it could consider establishing a
research fund. The biennial meeting is already a forum for
the dissemination of neuropsychiatric research.
An important development in 2004 was the publication
of the new journal Neuropsychiatric Disease and Treatment
(NDT), which is now the official journal of the INA although
its readership extends beyond. The journal meets many of
the objectives of the INA and is a handsome publication
with an assurance of the highest quality through its well
respected editors and editorial board. In some ways, NDT
may define the field for the next generation. It is therefore
important that members of the INA adopt it and use it as an
outlet for their best work. With NDT in tow, the INA is at
the dawn of a new phase of neuropsychiatric services and
research around the globe.